Arlington Trust’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Arlington Trust's TEVA Position: Q3 2026 in Review
Arlington Trust sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 92 shares — an estimated $3.12K sold.
Arlington Trust first reported a position in TEVA in Q4 2023 and held it in 3 quarters. The position peaked at $3.12K in Q2 2026. 600 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Arlington Trust reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
- Arlington Trust sold 92 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $3.12K.
- Arlington Trust first reported a position in Teva Pharmaceutical Industries in Q4 2023 and held it in 3 quarters.
- Arlington Trust's Teva Pharmaceutical Industries position peaked at $3.12K in Q2 2026.
- 600 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.